Status: current, Primitive. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4033009019 | Satralizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4033010012 | Satralizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Satralizumab | Is a | Immunosuppressant | true | Inferred relationship | Some | ||
| Satralizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Satralizumab | Is a | Interleukin 6 receptor antagonist | true | Inferred relationship | Some | ||
| Satralizumab | Has disposition | Interleukin 6 receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Satralizumab-containing product | Has active ingredient | True | Satralizumab | Inferred relationship | Some | 1 |
| Satralizumab only product | Has active ingredient | True | Satralizumab | Inferred relationship | Some | 1 |
| Satralizumab-containing product in parenteral dose form | Has active ingredient | True | Satralizumab | Inferred relationship | Some | 1 |
| Satralizumab only product in parenteral dose form | Has active ingredient | True | Satralizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR